Search Results - Hilder, Thomas L

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells

    Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells by Crose, Lisa E.S., Hilder, Thomas L., Sciaky, Noah, Johnson, Gary L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line

    Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line by Wang, Zihao, Hilder, Thomas L., van der Drift, Koen, Sloan, Jessica, Wee, Kevin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Proteomic Identification of the Cerebral Cavernous Malformation Signaling Complex

    Proteomic Identification of the Cerebral Cavernous Malformation Signaling Complex by Hilder, Thomas L, Malone, Michael H, Bencharit, Sompop, Colicelli, John, Haystead, Timothy A, Johnson, Gary L, Wu, Christine C

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle

    Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle by Hilder, Thomas L, Baer, Lisa A, Fuller, Patrick M, Fuller, Charles A, Grindeland, Richard E, Wade, Charles E, Graves, Lee M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle

    Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle by Hilder, Thomas L, Tou, Janet C.L, Grindeland, Richard E, Wade, Charles E, Graves, Lee M

    Published in FEBS letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Caspase-3 dependent cleavage and activation of skeletal muscle phosphorylase b kinase

    Caspase-3 dependent cleavage and activation of skeletal muscle phosphorylase b kinase by Hilder, Thomas L, Carlson, Gerald M, Haystead, Timothy A J, Krebs, Edwin G, Graves, Lee M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial CellsS

    Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial CellsS by Crose, Lisa E. S., Hilder, Thomas L., Sciaky, Noah, Johnson, Gary L.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a Phase 2 Study

    The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a... by Shah, Jatin J., Zonder, Jeffrey A., Cohen, Adam, Bensinger, William, Kaufman, Jonathan L., Orlowski, Robert Z., Harvey, R. Donald, Abidi, Muneer H., Thomas, Sheeba K., Walker, Duncan, Hilder, Brandi, Ptaszynski, Ann Marie, Lonial, Sagar

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    The Novel KSP Inhibitor ARRY-520 Demonstrates Single-Agent Activity in Refractory Myeloma: Results From a Phase 2 Trial in Patients with Relapsed/Refractory Multiple Myeloma (MM)

    The Novel KSP Inhibitor ARRY-520 Demonstrates Single-Agent Activity in Refractory Myeloma: Results From a Phase 2 Trial in Patients with Relapsed/Refractory Multiple Myeloma (MM) by Lonial, Sagar, Cohen, Adam, Zonder, Jeffrey, Benzinger, William I, Kaufman, Jonathan L., Orlowski, Robert Z., Harvey, R. Donald, Alexanian, Raymond, Thomas, Sheeba K, Weber, Donna, Walker, Duncan, Hilder, Brandi, Ptaszynski, Ann, Shah, Jatin J

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    ARRY-520 Shows Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Dose-Escalation Study

    ARRY-520 Shows Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Dose-Escalation Study by Shah, Jatin J, Zonder, Jeffrey, Cohen, Adam, Orlowski, Robert Z., Alexanian, Raymond, Thomas, Sheeba K, Weber, Donna, Kaufman, Jonathan L., Harvey, R. Donald, Walker, Duncan, Litwiler, Kevin, Karan, Sharon, Hilder, Brandi, Ptaszynski, Ann Marie, Lonial, Sagar

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    CoCoRo -- The Self-Aware Underwater Swarm

    CoCoRo -- The Self-Aware Underwater Swarm by Schmickl, T., Thenius, R., Moslinger, C., Timmis, J., Tyrrell, A., Read, M., Hilder, J., Halloy, J., Campo, A., Stefanini, C., Manfredi, L., Orofino, S., Kernbach, S., Dipper, T., Sutantyo, D.

    Request full text
    Items that cite this one
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: